In the latest quarter, 8 analysts provided ratings for AbbVie (NYSE:ABBV), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 6 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 4 | 0 | 0 | 0 |
Analysts have set 12-month price targets for AbbVie, revealing an average target of $189.75, a high estimate of $195.00, and a low estimate of $180.00. Witnessing a positive shift, the current average has risen by 3.12% from the previous average price target of $184.00.
Interpreting Analyst Ratings: A Closer Look
An in-depth analysis of recent analyst actions unveils how...
Login or create a forever free account to read this news
Sign up/Log in